HEADER TRANSFERASE 29-AUG-07 2R3S TITLE CRYSTAL STRUCTURE OF A PUTATIVE O-METHYLTRANSFERASE (NPUN_R0239) FROM TITLE 2 NOSTOC PUNCTIFORME PCC 73102 AT 2.15 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOSTOC PUNCTIFORME; SOURCE 3 ORGANISM_TAXID: 63737; SOURCE 4 STRAIN: PCC 73102; SOURCE 5 GENE: ZP_00112478.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS METHYLTRANSFERASE DOMAIN, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 24-JUL-19 2R3S 1 REMARK LINK REVDAT 5 25-OCT-17 2R3S 1 REMARK REVDAT 4 13-JUL-11 2R3S 1 VERSN REVDAT 3 28-JUL-10 2R3S 1 TITLE KEYWDS REVDAT 2 24-FEB-09 2R3S 1 VERSN REVDAT 1 11-SEP-07 2R3S 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN JRNL TITL 2 (ZP_00112478.1) FROM NOSTOC PUNCTIFORME PCC 73102 AT 2.15 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 44659 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2245 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3013 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.42 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 166 REMARK 3 BIN FREE R VALUE : 0.2860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4976 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 308 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 34.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.70000 REMARK 3 B22 (A**2) : 0.70000 REMARK 3 B33 (A**2) : -1.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.210 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.178 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.662 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5215 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3412 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7091 ; 1.348 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8377 ; 0.972 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 680 ; 6.218 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 223 ;33.654 ;24.888 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 830 ;14.860 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;17.323 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 816 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5853 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1036 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1100 ; 0.207 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3510 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2605 ; 0.179 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2504 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 314 ; 0.176 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.257 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 36 ; 0.236 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.205 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3433 ; 1.800 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1328 ; 0.537 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5335 ; 2.826 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2043 ; 4.693 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1741 ; 6.237 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 2 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 3 A 155 5 REMARK 3 1 B 3 B 155 5 REMARK 3 2 A 175 A 334 4 REMARK 3 2 B 175 B 334 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 2859 ; 0.290 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 920 ; 0.370 ; 5.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2859 ; 0.990 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 920 ; 2.340 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 136 REMARK 3 ORIGIN FOR THE GROUP (A): -19.5610 -20.9830 -72.4400 REMARK 3 T TENSOR REMARK 3 T11: -0.0170 T22: -0.0275 REMARK 3 T33: -0.1112 T12: -0.0313 REMARK 3 T13: -0.0125 T23: 0.0090 REMARK 3 L TENSOR REMARK 3 L11: 0.6462 L22: 0.8951 REMARK 3 L33: 0.8302 L12: 0.4088 REMARK 3 L13: -0.1156 L23: 0.0915 REMARK 3 S TENSOR REMARK 3 S11: 0.0642 S12: -0.0865 S13: 0.0530 REMARK 3 S21: 0.0092 S22: -0.0220 S23: 0.0242 REMARK 3 S31: -0.0895 S32: 0.2224 S33: -0.0422 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 136 REMARK 3 ORIGIN FOR THE GROUP (A): -19.4220 -39.1860 -78.9660 REMARK 3 T TENSOR REMARK 3 T11: -0.0257 T22: -0.0548 REMARK 3 T33: -0.1277 T12: 0.0075 REMARK 3 T13: 0.0062 T23: 0.0352 REMARK 3 L TENSOR REMARK 3 L11: 0.9523 L22: 1.4059 REMARK 3 L33: 1.6717 L12: 0.8381 REMARK 3 L13: 0.3058 L23: 0.4242 REMARK 3 S TENSOR REMARK 3 S11: 0.0372 S12: 0.0369 S13: -0.0875 REMARK 3 S21: -0.0026 S22: -0.0206 S23: -0.1062 REMARK 3 S31: 0.1538 S32: 0.1560 S33: -0.0166 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 3. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 4. THERE IS SOME UNMODELED DENSITY NEAR HIS 242 IN BOTH CHAINS. REMARK 3 5. CL AND ETHYLENE GLYCOL WERE MODELED BASED ON CRYSTALLIZATION REMARK 3 AND CRYO CONDITIONS. REMARK 4 REMARK 4 2R3S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-AUG-07. REMARK 100 THE DEPOSITION ID IS D_1000044388. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97901, 0.97925 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44737 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 29.696 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.250 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.59600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.250 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.2M SODIUM CHLORIDE, 1.0M REMARK 280 SODIUM CITRATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 90.26000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 46.95000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 46.95000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 45.13000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 46.95000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 46.95000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 135.39000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 46.95000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.95000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 45.13000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 46.95000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.95000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 135.39000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 90.26000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION REMARK 300 ON BURIED SURFACE AREA. REMARK 300 CRYSTAL STRUCTURE PACKING SUGGESTS THAT THE REMARK 300 BIOLOGICALLY RELEVANT FORM IS A DIMER. SIZE EXCLUSION REMARK 300 CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF A DIMER AS REMARK 300 A SIGNIFICANT OLIGOMERIZATION STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6120 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16090 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -180.52000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 SER A 2 REMARK 465 ASN A 161 REMARK 465 LYS A 162 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 SER B 124 REMARK 465 SER B 125 REMARK 465 GLU B 126 REMARK 465 GLY B 127 REMARK 465 ASN B 161 REMARK 465 LYS B 162 REMARK 465 ILE B 163 REMARK 465 GLU B 164 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 46 CD OE1 NE2 REMARK 470 ARG A 76 CZ NH1 NH2 REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 SER A 124 OG REMARK 470 ILE A 163 CG1 CG2 CD1 REMARK 470 GLU A 225 CD OE1 OE2 REMARK 470 ASP A 231 CG OD1 OD2 REMARK 470 GLU A 263 OE1 REMARK 470 ARG B 18 CZ NH1 NH2 REMARK 470 GLN B 46 CD OE1 NE2 REMARK 470 GLU B 73 CG CD OE1 OE2 REMARK 470 LYS B 90 CG CD CE NZ REMARK 470 GLU B 98 CG CD OE1 OE2 REMARK 470 SER B 130 OG REMARK 470 GLN B 138 OE1 NE2 REMARK 470 GLN B 156 CG CD OE1 NE2 REMARK 470 GLU B 225 CG CD OE1 OE2 REMARK 470 THR B 324 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 325 O HOH A 486 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 35 -127.83 51.77 REMARK 500 SER A 125 -124.52 69.82 REMARK 500 SER A 174 -127.67 56.03 REMARK 500 ASN A 296 14.57 -140.76 REMARK 500 ASN A 296 31.59 -148.81 REMARK 500 LEU A 322 72.64 49.61 REMARK 500 SER B 35 -136.88 55.72 REMARK 500 SER B 174 -123.86 54.42 REMARK 500 ASN B 296 18.64 -143.89 REMARK 500 LEU B 322 84.56 49.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 335 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 335 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 339 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 340 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 341 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 339 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 375748 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE FOLLOWED BY THE TARGET SEQUENCE. REMARK 999 THE SEQUENCE OF THIS PROTEIN WAS NOT AVAILABLE AT REMARK 999 THE UNIPROT DATABASE AT THE TIME OF DEPOSITION. DBREF 2R3S A 0 334 PDB 2R3S 2R3S 0 334 DBREF 2R3S B 0 334 PDB 2R3S 2R3S 0 334 SEQRES 1 A 335 GLY MSE SER THR PRO SER PRO ALA LEU PHE PHE ASN THR SEQRES 2 A 335 VAL ASN ALA TYR GLN ARG SER ALA ALA ILE LYS ALA ALA SEQRES 3 A 335 VAL GLU LEU ASN VAL PHE THR ALA ILE SER GLN GLY ILE SEQRES 4 A 335 GLU SER SER GLN SER LEU ALA GLN LYS CYS GLN THR SER SEQRES 5 A 335 GLU ARG GLY MSE ARG MSE LEU CYS ASP TYR LEU VAL ILE SEQRES 6 A 335 ILE GLY PHE MSE THR LYS GLN ALA GLU GLY TYR ARG LEU SEQRES 7 A 335 THR SER ASP SER ALA MSE PHE LEU ASP ARG GLN SER LYS SEQRES 8 A 335 PHE TYR VAL GLY ASP ALA ILE GLU PHE LEU LEU SER PRO SEQRES 9 A 335 MSE ILE THR ASN GLY PHE ASN ASP LEU THR ALA ALA VAL SEQRES 10 A 335 LEU LYS GLY GLY THR ALA ILE SER SER GLU GLY THR LEU SEQRES 11 A 335 SER PRO GLU HIS PRO VAL TRP VAL GLN PHE ALA LYS ALA SEQRES 12 A 335 MSE SER PRO MSE MSE ALA ASN PRO ALA GLN LEU ILE ALA SEQRES 13 A 335 GLN LEU VAL ASN GLU ASN LYS ILE GLU PRO LEU LYS VAL SEQRES 14 A 335 LEU ASP ILE SER ALA SER HIS GLY LEU PHE GLY ILE ALA SEQRES 15 A 335 VAL ALA GLN HIS ASN PRO ASN ALA GLU ILE PHE GLY VAL SEQRES 16 A 335 ASP TRP ALA SER VAL LEU GLU VAL ALA LYS GLU ASN ALA SEQRES 17 A 335 ARG ILE GLN GLY VAL ALA SER ARG TYR HIS THR ILE ALA SEQRES 18 A 335 GLY SER ALA PHE GLU VAL ASP TYR GLY ASN ASP TYR ASP SEQRES 19 A 335 LEU VAL LEU LEU PRO ASN PHE LEU HIS HIS PHE ASP VAL SEQRES 20 A 335 ALA THR CYS GLU GLN LEU LEU ARG LYS ILE LYS THR ALA SEQRES 21 A 335 LEU ALA VAL GLU GLY LYS VAL ILE VAL PHE ASP PHE ILE SEQRES 22 A 335 PRO ASN SER ASP ARG ILE THR PRO PRO ASP ALA ALA ALA SEQRES 23 A 335 PHE SER LEU VAL MSE LEU ALA THR THR PRO ASN GLY ASP SEQRES 24 A 335 ALA TYR THR PHE ALA GLU TYR GLU SER MSE PHE SER ASN SEQRES 25 A 335 ALA GLY PHE SER HIS SER GLN LEU HIS SER LEU PRO THR SEQRES 26 A 335 THR GLN GLN GLN VAL ILE VAL ALA TYR LYS SEQRES 1 B 335 GLY MSE SER THR PRO SER PRO ALA LEU PHE PHE ASN THR SEQRES 2 B 335 VAL ASN ALA TYR GLN ARG SER ALA ALA ILE LYS ALA ALA SEQRES 3 B 335 VAL GLU LEU ASN VAL PHE THR ALA ILE SER GLN GLY ILE SEQRES 4 B 335 GLU SER SER GLN SER LEU ALA GLN LYS CYS GLN THR SER SEQRES 5 B 335 GLU ARG GLY MSE ARG MSE LEU CYS ASP TYR LEU VAL ILE SEQRES 6 B 335 ILE GLY PHE MSE THR LYS GLN ALA GLU GLY TYR ARG LEU SEQRES 7 B 335 THR SER ASP SER ALA MSE PHE LEU ASP ARG GLN SER LYS SEQRES 8 B 335 PHE TYR VAL GLY ASP ALA ILE GLU PHE LEU LEU SER PRO SEQRES 9 B 335 MSE ILE THR ASN GLY PHE ASN ASP LEU THR ALA ALA VAL SEQRES 10 B 335 LEU LYS GLY GLY THR ALA ILE SER SER GLU GLY THR LEU SEQRES 11 B 335 SER PRO GLU HIS PRO VAL TRP VAL GLN PHE ALA LYS ALA SEQRES 12 B 335 MSE SER PRO MSE MSE ALA ASN PRO ALA GLN LEU ILE ALA SEQRES 13 B 335 GLN LEU VAL ASN GLU ASN LYS ILE GLU PRO LEU LYS VAL SEQRES 14 B 335 LEU ASP ILE SER ALA SER HIS GLY LEU PHE GLY ILE ALA SEQRES 15 B 335 VAL ALA GLN HIS ASN PRO ASN ALA GLU ILE PHE GLY VAL SEQRES 16 B 335 ASP TRP ALA SER VAL LEU GLU VAL ALA LYS GLU ASN ALA SEQRES 17 B 335 ARG ILE GLN GLY VAL ALA SER ARG TYR HIS THR ILE ALA SEQRES 18 B 335 GLY SER ALA PHE GLU VAL ASP TYR GLY ASN ASP TYR ASP SEQRES 19 B 335 LEU VAL LEU LEU PRO ASN PHE LEU HIS HIS PHE ASP VAL SEQRES 20 B 335 ALA THR CYS GLU GLN LEU LEU ARG LYS ILE LYS THR ALA SEQRES 21 B 335 LEU ALA VAL GLU GLY LYS VAL ILE VAL PHE ASP PHE ILE SEQRES 22 B 335 PRO ASN SER ASP ARG ILE THR PRO PRO ASP ALA ALA ALA SEQRES 23 B 335 PHE SER LEU VAL MSE LEU ALA THR THR PRO ASN GLY ASP SEQRES 24 B 335 ALA TYR THR PHE ALA GLU TYR GLU SER MSE PHE SER ASN SEQRES 25 B 335 ALA GLY PHE SER HIS SER GLN LEU HIS SER LEU PRO THR SEQRES 26 B 335 THR GLN GLN GLN VAL ILE VAL ALA TYR LYS MODRES 2R3S MSE A 55 MET SELENOMETHIONINE MODRES 2R3S MSE A 57 MET SELENOMETHIONINE MODRES 2R3S MSE A 68 MET SELENOMETHIONINE MODRES 2R3S MSE A 83 MET SELENOMETHIONINE MODRES 2R3S MSE A 104 MET SELENOMETHIONINE MODRES 2R3S MSE A 143 MET SELENOMETHIONINE MODRES 2R3S MSE A 146 MET SELENOMETHIONINE MODRES 2R3S MSE A 147 MET SELENOMETHIONINE MODRES 2R3S MSE A 290 MET SELENOMETHIONINE MODRES 2R3S MSE A 308 MET SELENOMETHIONINE MODRES 2R3S MSE B 55 MET SELENOMETHIONINE MODRES 2R3S MSE B 57 MET SELENOMETHIONINE MODRES 2R3S MSE B 68 MET SELENOMETHIONINE MODRES 2R3S MSE B 83 MET SELENOMETHIONINE MODRES 2R3S MSE B 104 MET SELENOMETHIONINE MODRES 2R3S MSE B 143 MET SELENOMETHIONINE MODRES 2R3S MSE B 146 MET SELENOMETHIONINE MODRES 2R3S MSE B 147 MET SELENOMETHIONINE MODRES 2R3S MSE B 290 MET SELENOMETHIONINE MODRES 2R3S MSE B 308 MET SELENOMETHIONINE HET MSE A 55 8 HET MSE A 57 8 HET MSE A 68 8 HET MSE A 83 13 HET MSE A 104 13 HET MSE A 143 8 HET MSE A 146 8 HET MSE A 147 8 HET MSE A 290 8 HET MSE A 308 8 HET MSE B 55 8 HET MSE B 57 8 HET MSE B 68 8 HET MSE B 83 8 HET MSE B 104 13 HET MSE B 143 8 HET MSE B 146 13 HET MSE B 147 8 HET MSE B 290 8 HET MSE B 308 8 HET CL A 335 1 HET EDO A 336 4 HET EDO A 337 4 HET EDO A 338 4 HET EDO A 339 4 HET EDO A 340 4 HET EDO A 341 4 HET CL B 335 1 HET EDO B 336 4 HET EDO B 337 4 HET EDO B 338 4 HET EDO B 339 4 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 20(C5 H11 N O2 SE) FORMUL 3 CL 2(CL 1-) FORMUL 4 EDO 10(C2 H6 O2) FORMUL 15 HOH *308(H2 O) HELIX 1 1 PRO A 6 ASN A 14 1 9 HELIX 2 2 ALA A 15 LEU A 28 1 14 HELIX 3 3 ASN A 29 SER A 35 1 7 HELIX 4 4 SER A 40 GLN A 49 1 10 HELIX 5 5 SER A 51 ILE A 65 1 15 HELIX 6 6 THR A 78 LEU A 85 1 8 HELIX 7 7 VAL A 93 ASP A 95 5 3 HELIX 8 8 ALA A 96 LEU A 101 1 6 HELIX 9 9 SER A 102 ASN A 107 1 6 HELIX 10 10 GLY A 108 ASN A 110 5 3 HELIX 11 11 ASP A 111 GLY A 119 1 9 HELIX 12 12 GLU A 126 SER A 130 5 5 HELIX 13 13 PRO A 134 MSE A 143 1 10 HELIX 14 14 SER A 144 MSE A 146 5 3 HELIX 15 15 MSE A 147 ASN A 159 1 13 HELIX 16 16 GLY A 176 ASN A 186 1 11 HELIX 17 17 TRP A 196 GLY A 211 1 16 HELIX 18 18 VAL A 212 SER A 214 5 3 HELIX 19 19 PHE A 240 PHE A 244 5 5 HELIX 20 20 ASP A 245 ALA A 259 1 15 HELIX 21 21 PRO A 280 THR A 294 1 15 HELIX 22 22 THR A 301 ALA A 312 1 12 HELIX 23 23 PRO B 6 ASN B 14 1 9 HELIX 24 24 ALA B 15 ASN B 29 1 15 HELIX 25 25 ASN B 29 SER B 35 1 7 HELIX 26 26 SER B 40 GLN B 49 1 10 HELIX 27 27 SER B 51 ILE B 65 1 15 HELIX 28 28 THR B 78 LEU B 85 1 8 HELIX 29 29 VAL B 93 ASP B 95 5 3 HELIX 30 30 ALA B 96 LEU B 101 1 6 HELIX 31 31 SER B 102 ASP B 111 1 10 HELIX 32 32 ASP B 111 GLY B 119 1 9 HELIX 33 33 PRO B 134 MSE B 143 1 10 HELIX 34 34 MSE B 143 ASN B 159 1 17 HELIX 35 35 GLY B 176 ASN B 186 1 11 HELIX 36 36 TRP B 196 GLN B 210 1 15 HELIX 37 37 VAL B 212 SER B 214 5 3 HELIX 38 38 PHE B 240 PHE B 244 5 5 HELIX 39 39 ASP B 245 ALA B 259 1 15 HELIX 40 40 PRO B 280 THR B 294 1 15 HELIX 41 41 THR B 301 ALA B 312 1 12 SHEET 1 A 3 ILE A 38 GLU A 39 0 SHEET 2 A 3 GLY A 74 LEU A 77 -1 O TYR A 75 N GLU A 39 SHEET 3 A 3 MSE A 68 GLN A 71 -1 N GLN A 71 O GLY A 74 SHEET 1 B 7 TYR A 216 ALA A 220 0 SHEET 2 B 7 GLU A 190 ASP A 195 1 N ILE A 191 O HIS A 217 SHEET 3 B 7 LYS A 167 ILE A 171 1 N ASP A 170 O PHE A 192 SHEET 4 B 7 TYR A 232 PRO A 238 1 O LEU A 236 N LEU A 169 SHEET 5 B 7 LEU A 260 ASP A 270 1 O ILE A 267 N LEU A 237 SHEET 6 B 7 GLN A 328 TYR A 333 -1 O ILE A 330 N VAL A 268 SHEET 7 B 7 HIS A 316 HIS A 320 -1 N HIS A 320 O VAL A 329 SHEET 1 C 2 MSE B 68 GLN B 71 0 SHEET 2 C 2 GLY B 74 LEU B 77 -1 O ARG B 76 N THR B 69 SHEET 1 D 7 TYR B 216 ALA B 220 0 SHEET 2 D 7 GLU B 190 ASP B 195 1 N ILE B 191 O HIS B 217 SHEET 3 D 7 LYS B 167 ILE B 171 1 N VAL B 168 O GLU B 190 SHEET 4 D 7 TYR B 232 PRO B 238 1 O LEU B 236 N LEU B 169 SHEET 5 D 7 LEU B 260 ASP B 270 1 O ILE B 267 N VAL B 235 SHEET 6 D 7 GLN B 328 TYR B 333 -1 O ILE B 330 N VAL B 268 SHEET 7 D 7 HIS B 316 HIS B 320 -1 N HIS B 316 O TYR B 333 LINK C GLY A 54 N MSE A 55 1555 1555 1.34 LINK C MSE A 55 N ARG A 56 1555 1555 1.33 LINK C ARG A 56 N MSE A 57 1555 1555 1.33 LINK C MSE A 57 N LEU A 58 1555 1555 1.35 LINK C PHE A 67 N MSE A 68 1555 1555 1.31 LINK C MSE A 68 N THR A 69 1555 1555 1.33 LINK C ALA A 82 N MSE A 83 1555 1555 1.32 LINK C MSE A 83 N PHE A 84 1555 1555 1.32 LINK C PRO A 103 N MSE A 104 1555 1555 1.32 LINK C MSE A 104 N ILE A 105 1555 1555 1.33 LINK C ALA A 142 N MSE A 143 1555 1555 1.33 LINK C MSE A 143 N SER A 144 1555 1555 1.33 LINK C PRO A 145 N MSE A 146 1555 1555 1.33 LINK C MSE A 146 N MSE A 147 1555 1555 1.34 LINK C MSE A 147 N ALA A 148 1555 1555 1.33 LINK C VAL A 289 N MSE A 290 1555 1555 1.33 LINK C MSE A 290 N LEU A 291 1555 1555 1.32 LINK C SER A 307 N MSE A 308 1555 1555 1.33 LINK C MSE A 308 N PHE A 309 1555 1555 1.32 LINK C GLY B 54 N MSE B 55 1555 1555 1.33 LINK C MSE B 55 N ARG B 56 1555 1555 1.34 LINK C ARG B 56 N MSE B 57 1555 1555 1.33 LINK C MSE B 57 N LEU B 58 1555 1555 1.34 LINK C PHE B 67 N MSE B 68 1555 1555 1.33 LINK C MSE B 68 N THR B 69 1555 1555 1.32 LINK C ALA B 82 N MSE B 83 1555 1555 1.32 LINK C MSE B 83 N PHE B 84 1555 1555 1.34 LINK C PRO B 103 N MSE B 104 1555 1555 1.32 LINK C MSE B 104 N ILE B 105 1555 1555 1.35 LINK C ALA B 142 N MSE B 143 1555 1555 1.33 LINK C MSE B 143 N SER B 144 1555 1555 1.33 LINK C PRO B 145 N MSE B 146 1555 1555 1.34 LINK C MSE B 146 N MSE B 147 1555 1555 1.34 LINK C MSE B 147 N ALA B 148 1555 1555 1.34 LINK C VAL B 289 N MSE B 290 1555 1555 1.33 LINK C MSE B 290 N LEU B 291 1555 1555 1.34 LINK C SER B 307 N MSE B 308 1555 1555 1.33 LINK C MSE B 308 N PHE B 309 1555 1555 1.33 CISPEP 1 THR A 279 PRO A 280 0 -11.34 CISPEP 2 THR B 279 PRO B 280 0 -10.83 SITE 1 AC1 4 PHE B 139 HIS B 175 ASN B 239 HOH B 418 SITE 1 AC2 3 HIS A 175 ASN A 239 EDO A 337 SITE 1 AC3 8 VAL A 194 ASP A 195 TRP A 196 GLY A 221 SITE 2 AC3 8 SER A 222 ALA A 223 EDO A 341 HOH A 420 SITE 1 AC4 4 SER B 172 PRO B 238 ASN B 239 HOH B 418 SITE 1 AC5 5 SER A 172 SER A 174 PRO A 238 ASN A 239 SITE 2 AC5 5 CL A 335 SITE 1 AC6 5 ARG A 18 HOH A 419 ASN B 11 THR B 12 SITE 2 AC6 5 ARG B 18 SITE 1 AC7 5 GLY A 211 LYS B 141 VAL B 202 GLU B 205 SITE 2 AC7 5 HOH B 464 SITE 1 AC8 2 MSE A 146 GLN A 326 SITE 1 AC9 3 TRP A 196 HIS A 243 EDO A 336 SITE 1 BC1 2 HIS B 217 THR B 218 SITE 1 BC2 3 ASN B 29 ALA B 33 LYS B 47 SITE 1 BC3 6 ASP B 195 TRP B 196 GLY B 221 SER B 222 SITE 2 BC3 6 ALA B 223 HOH B 340 CRYST1 93.900 93.900 180.520 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010650 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010650 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005540 0.00000